PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-10-17 (2)

Date Title Company
17-Oct-2023 Bloomsbury Genetic Therapies Receives Orphan Drug Designations from the European Commission and the US FDA for BGT-NPC for the Treatment of Niemann-Pick Disease Type C and Provides Update on Type B Pre-IND Interaction with the US FDA Bloomsbury Genetic Therapies Limited
17-Oct-2023 Data Dreamland Conference Brings Together Top Experts in Cost-Efficient Data Solutions Scalefree International GmbH
17-Oct-2023 AI startup Leucine nets $7M to level up Pharma manufacturing compliance to keep pace with drug innovation Leucine nets $7M to level up pharma manufacturing compliance to keep pace with drug innovation
17-Oct-2023 Tilray Medical Supports New Clinical Trial to Study Medical Cannabis in Glioblastoma Cancer Treatment Tilray Medical
17-Oct-2023 Navin Fluorine International Ltd. launches Navin Molecular: The new brand for its future-thinking CDMO business Navin Fluorine International Ltd
17-Oct-2023 Lytix Biopharma’s abstract with preliminary data from the ATLAS-IT-05 study is published. Lytix Biopharma
17-Oct-2023 SOTIO Enters Licensing Agreement With Synaffix to Expand ADC Pipeline Synaffix B.V.
17-Oct-2023 Coriolis Pharma Announces Strategic Growth Partnership With KKR and Frontier Biosolutions Coriolis Pharma
17-Oct-2023 Anaveon announces poster presentation at the 2023 European Society for Medical Oncology Annual Meeting Anaveon
17-Oct-2023 Data Presented at UEG Week 2023 Further Support the Potential of Celltrion’s Investigational Subcutaneous Infliximab CT-P13 SC in the Treatment of Inflammatory Bowel Disease Businesswire